Journal of Addiction Research & Therapy
Open Access

Chen L, Nath R (2016) Understanding the underlying factors of Internet addiction across cultures: A comparison study. Electronic Commerce Research and Applications 17: 38-48.

Jeromin F, Rief W, Barke A (2016) Validation of the Internet Gaming Disorder Questionnaire in a Sample of Adult German-Speaking Internet Gamers. Cyberpsychology, Behavior, and Social Networking 19: 453-459.

Jeromin F, Nyenhuis N, Barke A (2016) Attentional bias in excessive Internet gamers: Experimental investigations using an addiction Stroop and a visual probe. Journal of Behavioral Addictions 5: 32-40.

Tolchard B (2016) Cognitive-behavior therapy for problem gambling: a critique of current treatments and proposed new unified approach. Journal of Mental Health 14: 1-8.

Harris N, Mazmanian D (2016) Problem Internet Gamblers’ Perspectives on Cognitive Behavioural Group Therapy. International Journal of Mental Health and Addiction 14: 885-895.

Nower L, Caler K. Encyclopedia of Social Work.

Beard E, Brown J, Kaner E, West R, Michie S (2017) Predictors of and reasons for attempts to reduce alcohol intake: A population survey of adults in England. PLoS one 12: e0173458.

Leeman RF, Patock-Peckham JA, Potenza MN (2012) Impaired control over alcohol use: An under-addressed risk factor for problem drinking in young adults?. Experimental and clinical psychopharmacology 20: 92.

Elmore JS, Dillon-Carter O, Partilla JS, Ellefsen KN, Concheiro M, et al. (2016) Pharmacokinetic Profiles and Pharmacodynamic Effects for Methylone and Its Metabolites in Rats. Neuropsychopharmacology.

Burrows BT, Watterson LR, Johnson MA, Olive MF (2015) Effects of modafinil and R-modafinil on brain stimulation reward thresholds: implications for their use in the treatment of psychostimulant dependence. Journal of drug and alcohol research.

Woloshchuk CJ, Nelson KH, Rice KC, Riley AL (2016) Effects of 3, 4-methylenedioxypyrovalerone (MDPV) pre-exposure on the aversive effects of MDPV, cocaine and lithium chloride: Implications for abuse vulnerability. Drug and Alcohol Dependence 167: 121-127.

Baumann MH, Bukhari MO, Lehner KR, Anizan S, Rice KC, Concheiro M, Huestis MA. Neuropharmacology of 3, 4-Methylenedioxypyrovalerone (MDPV), Its Metabolites, and Related Analogs.

Anneken JH, Angoa-Pérez M, Sati GC, Crich D, Kuhn DM (2017) Dissecting the Influence of Two Structural Substituents on the Differential Neurotoxic Effects of Acute Methamphetamine and Mephedrone Treatment on Dopamine Nerve Endings with the Use of 4-Methylmethamphetamine and Methcathinone. Journal of Pharmacology and Experimental Therapeutics 360: 417-423.

Botanas CJ, Yoon SS, de la Peña JB, dela Peña IJ, Kim M, et al. (2017) A novel synthetic cathinone, 2-(methylamino)-1-(naphthalen-2-yl) propan-1-one (BMAPN), produced rewarding effects and altered striatal dopamine-related gene expression in mice. Behavioural brain research 317: 494-501.

Oh JH, Hwang JY, Hong SI, Ma SX, Seo JY, et al. (2016) The new designer drug buphedrone produces rewarding properties via dopamine D1 receptor activation. Addiction biology.

Fratantonio J, Andrade L, Febo M (2015) Designer Drugs: A Synthetic Catastrophe. Journal of reward deficiency syndrome 1: 82.

Daniel JJ, Hughes RN (2016) Increased anxiety and impaired spatial memory in young adult rats following adolescent exposure to methylone. Pharmacology Biochemistry and Behavior 146: 44-49.

Aarde SM, Taffe MA. Predicting the Abuse Liability of Entactogen-Class, New and Emerging Psychoactive Substances via Preclinical Models of Drug Self-administration.